Search details
1.
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.
Cancers (Basel)
; 13(22)2021 11 09.
Article
in English
| MEDLINE | ID: mdl-34830761
2.
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.
Hemasphere
; 7(9): e940, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37663673
3.
Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma.
Hemasphere
; 6(7): e744, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35813097
Results
1 -
3
de 3
1
Next >
>>